Clinical and oncological outcomes of pelvic exenteration surgery for anal squamous cell carcinoma
Quyn A, Murthy S, Gould L, Said H, Tiernan J, Sagar P, Antoniou A, Jenkins I, Burns E. Clinical and oncological outcomes of pelvic exenteration surgery for anal squamous cell carcinoma. Colorectal Disease 2023, 25: 2131-2138. PMID: 37753947, DOI: 10.1111/codi.16736.Peer-Reviewed Original ResearchConceptsAnal squamous cell carcinomaSquamous cell carcinomaDisease-free survivalR0 resectionR1/R2 resectionPelvic exenterationOverall survivalRecurrent diseaseCell carcinomaTreated with pelvic exenterationComplete R0 resectionPelvic exenteration surgeryAnal cancer incidenceR0 resection rateMedian follow-upPoorer overall survivalR1/2 resectionR1 resectionR2 resectionExenteration surgeryOncological outcomesResection ratePrimary endpointRetrospective reviewTreatment modalities
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply